BPC-157, also known as Body Protection Compound-157, is a synthetic peptide consisting of 15 amino acids. It is derived from a sequence found in human gastric juices and is frequently studied for its role in tissue repair and inflammation research.

BPC-157: Research Overview

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids derived from a sequence found in human gastric juice. It has been extensively studied in preclinical models for its cytoprotective and tissue-regenerative properties across multiple organ systems. BPC-157 is notable for its stability in both acidic (gastric) and physiological pH environments, and it demonstrates activity following systemic and local application in animal models.

Key areas of preclinical investigation include:

• Tendon and Ligament Repair: BPC-157 has demonstrated accelerated healing of tendon-to-bone attachments and ligament tears in rodent models, associated with upregulation of growth factor receptors (VEGFR2, FGFR2) at injury sites. (Krivic et al., 2006)
• Gastrointestinal Cytoprotection: Originally studied for gastric ulcer and inflammatory bowel disease models, BPC-157 modulates nitric oxide (NO) systems and influences angiogenesis in intestinal tissue.
• Neurological Pathways: Animal studies indicate BPC-157 may influence dopaminergic and serotonergic neurotransmission, with implications for neurobehavioral and neuroprotective research.
• Angiogenesis Promotion: BPC-157 stimulates VEGF upregulation and promotes neovascularization at wound sites, contributing to its observed regenerative properties in multiple tissue types.

BPC-157 is commonly studied alongside TB-500 (Thymosin Beta-4) in tissue repair research, as the two peptides target complementary aspects of the healing cascade — BPC-157 through angiogenic and growth factor pathways, TB-500 through actin cytoskeletal dynamics and cell migration. For protocols combining both, see our Wolverine BPC-157 + TB-500 Blend and the Stacking Peptides Research Guide.

Research Context: BPC-157 in the Tissue Repair Peptide Landscape

Tissue repair and regenerative peptide research encompasses several compounds with distinct but often synergistic mechanisms. BPC-157 is among the most studied:

• BPC-157 — Gastric pentadecapeptide; VEGF/angiogenesis, NO modulation, multi-tissue cytoprotection
• TB-500 (Thymosin Beta-4) — Actin-sequestering peptide; cell migration, differentiation, muscle and connective tissue repair
• Wolverine Blend (BPC-157 + TB-500) — Pre-formulated combination stack for comprehensive tissue repair research
• AOD-9604 — hGH fragment; metabolic/lipolytic research (distinct mechanism but sometimes co-studied)
• Thymosin Alpha 1 — Thymic peptide; immune modulation research (same thymosin family, different biological target)

BPC-157 and TB-500 together represent the most studied peptide pair in preclinical musculoskeletal research, with overlapping indications but distinct molecular targets.

Related Research Resources

• What Are Peptides: The Complete 2026 Research Guide
• Peptide Stacking Research Guide: Synergistic Combinations
• How to Reconstitute Peptides Safely for R&D
• Quality Control in Peptide Research: Interpreting Purity
• Peptide Safety 101: Finding the Safest Place to Buy Peptides

Key Properties

Tissue Repair:

• Investigated for its potential to influence cellular regeneration and tissue remodelling processes.

Angiogenesis Research:

• Explored for its role in promoting blood vessel formation to support nutrient delivery in laboratory models.

Inflammation Studies:

• Studied for its potential interactions with inflammatory pathways and cellular responses.

Applications in Research

BPC-157 is widely researched in controlled laboratory environments for its potential effects on:

• Tissue regeneration and wound healing mechanisms.
• Pathways associated with angiogenesis and blood flow.
• Biochemical processes involving inflammatory responses.

These studies are conducted in laboratory settings.

Storage and Handling Instructions

• Store BPC-157 in its lyophilized form at -4°F (-20°C) or lower to maintain stability.
• Protect from light, moisture, and excessive heat.
• Discard unused or reconstituted solutions promptly after use in compliance with research protocols.

Safety Information

This product is intended for research purposes. You must:

• Follow institutional guidelines for safe handling and storage.
• Use appropriate personal protective equipment.
• Ensure proper disposal of the product according to regulatory standards.

Frequently Asked Questions

What is BPC-157 and what does it do in research settings?

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids derived from a partial sequence of human gastric juice proteins. In preclinical research models, it has been investigated for its influence on tissue regeneration, angiogenesis, and inflammatory pathway modulation. All studies are conducted in controlled laboratory environments.

What is the molecular structure of BPC-157?

BPC-157 has the amino acid sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, with a molecular weight of approximately 1,419 Da. Its stability in gastric conditions distinguishes it from many other research peptides, making it a subject of interest in gastrointestinal research protocols.

How should BPC-157 be stored for research use?

Lyophilized BPC-157 should be stored at -4°F (-20°C) or lower in a light-protected, moisture-free environment. Once reconstituted for laboratory use, the solution should be used promptly according to the research protocol. Extended storage of reconstituted peptide is not recommended.

What purity standards should researchers look for?

Research-grade BPC-157 should meet a minimum purity threshold of ≥98%, verified through HPLC (High-Performance Liquid Chromatography) analysis. A in-house purity testing should confirm consistency across batches. Look for peptides made and tested in the USA.

What areas of research have studied BPC-157?

Published preclinical studies have investigated BPC-157 across several domains including: tissue repair and wound healing mechanisms, blood vessel formation (angiogenesis), inflammatory response modulation, gastrointestinal mucosal integrity, and musculoskeletal tissue recovery. These investigations have been conducted exclusively in laboratory and animal model settings.

How is BPC-157 prepared for laboratory research?

BPC-157 is typically reconstituted with bacteriostatic water or sterile saline according to the specific research protocol. Researchers should use calibrated instruments for accurate measurement and follow institutional guidelines for peptide handling, storage, and disposal throughout the research process.

References

1. Gwyer D, Wragg NM, Wilson SL. "Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing." Cell Tissue Res. 2019;377(2):153-159. PubMed
2. Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. "The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration." J Appl Physiol. 2011;110(3):774-80. PubMed
3. Seiwerth S, Milavic M, Vukojevic J, et al. "Stable Gastric Pentadecapeptide BPC 157 and Wound Healing." Front Pharmacol. 2021;12:627533. PubMed
4. Vukojevic J, Milavić M, Perović D, et al. "Pentadecapeptide BPC 157 and the central nervous system." Neural Regen Res. 2022;17(3):482-487. PubMed